SCHEMBL6000730

SCHEMBL6000730

CCCC(CCC)c1ccc(COc2ccc(-c3csc(CN4CCN(c5ccccc5C(=O)O)CC4)n3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.54
PTPN1 P18031 1/20 0.54
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 2/20 0.43
DRD4 P21917 1/20 0.42
ALOX5 P09917 3/20 0.39
FFAR1 O14842 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 2/20 0.37
MEN1 O00255 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
HTT P42858 2/20 0.36
ENPP2 Q13822 1/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000399 0.87 PTPN2 (0.55) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL6000725 0.86 PTPN2 (0.55) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL6000163 0.86 PTPN2 (0.55) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL5999093 0.85 PTPN2 (0.53) PTPN2PTPN1KMT2AALDH1A1DRD4
Hydrochloric Acid SCHEMBL6000737 0.82 PTPN2 (0.59) PTPN2PTPN1KMT2AALDH1A1ALOX5
Hydrochloric Acid SCHEMBL6000773 0.82 PTPN2 (0.59) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL5999145 0.81 PTPN2 (0.56) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL6000477 0.80 PTPN2 (0.53) PTPN2PTPN1KMT2AALDH1A1ALOX5
SCHEMBL6000619 0.79 PTPN2 (0.55) PTPN2PTPN1ALOX5FFAR1PPARD
SCHEMBL6000482 0.78 PTPN2 (0.53) PTPN2PTPN1KMT2AALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885KMT2A 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.